Prevalence and perceptions of pain in people with haemophilia: A UK study

Haemophilia. 2023 Nov;29(6):1509-1518. doi: 10.1111/hae.14860. Epub 2023 Sep 11.

Abstract

Introduction: Joint bleeds in haemophilia cause destruction of articular structures, impaired function and pain. Up to 70% of people with haemophilia (PWH) report chronic pain. Little is known about the pain experiences in PWH in the UK.

Aim: To identify prevalence and perceptions of pain among PWH living in the UK.

Methods: A cross-sectional, non-interventional survey study conducted among PWH (all severities). The survey incorporated elements from validated tools (EQ-5D; EQ-VAS) and was distributed via participating treatment centres.

Results: Five hundred and ninety-nine PWH responded, 91% aged > 18. 81% used factor prophylactically or on demand. More pain was reported by those treated on demand versus prophylaxis particularly in those who reported daily pain. 65% reported 'problem joints' based on individual impact rather than medically defined 'target joints', 2/3 reported multiple joint issues. The ankle was most commonly affected. 59% reported frequent pain, with 56% aware of pain constantly or most of the time and were more likely to report less favourable EQ-5D or EQ-VAS scores (p < .001). Pain frequency/awareness was consistent across all severities. Most discussed pain with care teams, 31% only when asked; 25% did not discuss it. Pain discussions resulted in physiotherapy referral (63%) analgesia prescription (48%), and a minority specialist pain referral (9%). Most felt well supported with regard to their pain, but 70% reported learning to live with it.

Conclusion: Pain affects PWH of all ages and severities even in a well-resourced country significantly impacting quality of life. Clinicians must be more aware of chronic pain in PWH. Biopsychosocial approaches to pain assessment and management are recommended.

Keywords: belief; haemophilia; lived-experience; pain.

MeSH terms

  • Chronic Pain* / epidemiology
  • Cross-Sectional Studies
  • Hemophilia A* / complications
  • Hemophilia A* / epidemiology
  • Hemophilia A* / psychology
  • Humans
  • Prevalence
  • Quality of Life
  • United Kingdom / epidemiology